• 1. Evolution study of photo-synthesized gold nanoparticles by spectral deconvolution model: a quantitative approach
  Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 4. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 5. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Keto acids and derivatives Beta-keto acids and derivatives

Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester (CAS No. 66696-98-8): A Comprehensive Overview

Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester, with the CAS number 66696-98-8, is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, also known as tert-butyl acetoacetate, is a derivative of heptanoic acid featuring a β-ketoester structure. Its unique molecular configuration makes it a valuable intermediate in organic synthesis and has potential applications in various biochemical processes.

The structure of Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester consists of a heptanoic acid backbone with a ketone group at the third carbon and an ester group at the terminal carbon, which is further substituted with a tert-butyl group. This specific arrangement imparts distinct chemical properties that make it useful in synthetic chemistry, particularly in the preparation of more complex molecules. The presence of both a keto and an ester functionality allows for diverse reactions, including condensation reactions, Michael additions, and enolate formation, which are pivotal in the synthesis of pharmaceuticals and fine chemicals.

In recent years, there has been growing interest in the applications of β-ketoesters like Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester due to their role as key intermediates in the synthesis of active pharmaceutical ingredients (APIs). The compound's ability to undergo various transformations under controlled conditions makes it an attractive candidate for industrial-scale production. For instance, it can be used to synthesize chiral compounds through asymmetric synthesis methods, which are crucial for developing enantiomerically pure drugs with enhanced efficacy and reduced side effects.

One of the most notable applications of Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester is in the field of agrochemicals. The β-ketoester moiety can be readily converted into other functional groups, making it a versatile building block for herbicides and pesticides. Researchers have explored its derivatives as potential candidates for next-generation crop protection agents due to their structural similarity to known bioactive compounds. These studies have highlighted the compound's potential in developing environmentally friendly agrochemicals that are both effective and sustainable.

The pharmaceutical industry has also leveraged the unique properties of Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester in drug discovery and development. Its reactivity allows for the synthesis of complex molecular architectures that are essential for drug design. For example, it has been utilized in the preparation of protease inhibitors and kinase inhibitors, which are critical in treating diseases such as cancer and infectious disorders. The compound's ability to act as a precursor for these drugs underscores its importance in medicinal chemistry.

Recent advancements in synthetic methodologies have further expanded the utility of Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester. Techniques such as flow chemistry and continuous manufacturing have enabled more efficient and scalable production processes for this compound. These innovations have not only improved yield but also reduced waste generation, aligning with the growing emphasis on green chemistry principles. The ability to produce high-purity batches of this compound under controlled conditions is essential for its application in sensitive pharmaceutical processes.

The biological activity of derivatives of Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester has been extensively studied. Researchers have found that certain modifications to its structure can enhance its bioavailability and target specificity. For instance, incorporating fluorine atoms or other heteroatoms into its molecular framework can modulate its pharmacokinetic properties. Such modifications are crucial for optimizing drug candidates for clinical use.

In conclusion, Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester (CAS No. 66696-98-8) is a multifaceted compound with significant potential in various scientific domains. Its unique structural features make it an invaluable intermediate in organic synthesis, pharmaceutical development, and agrochemical production. As research continues to uncover new applications and synthetic strategies for this compound, its importance is likely to grow further. The ongoing development of innovative methodologies ensures that Heptanoic acid, 3-oxo-, 1,1-dimethylethyl ester will remain at the forefront of chemical research and industrial applications.

• 28009-80-5(Pentanedioic acid,3-oxo-, 1,5-bis(1,1-dimethylethyl) ester)
• 542-08-5(Isopropyl acetoacetate)
• 1694-31-1(Tert-butyl acetoacetate)
• 13562-81-7(Acetoacetic Acid 3-Pentyl Ester)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)